Mackenzie Financial Corp Has $4.83 Million Stake in Cognex Co. (CGNX)

Mackenzie Financial Corp lifted its position in Cognex Co. (NASDAQ:CGNX) by 19.9% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 43,751 shares of the scientific and technical instruments company’s stock after acquiring an additional 7,259 shares during the quarter. Mackenzie Financial Corp owned 0.05% of Cognex worth $4,825,000 at the end of the most recent reporting period.

Several other institutional investors have also recently added to or reduced their stakes in the company. Janney Montgomery Scott LLC lifted its holdings in Cognex by 6.0% during the 2nd quarter. Janney Montgomery Scott LLC now owns 9,559 shares of the scientific and technical instruments company’s stock valued at $812,000 after buying an additional 541 shares in the last quarter. Great West Life Assurance Co. Can lifted its holdings in Cognex by 1.3% during the 2nd quarter. Great West Life Assurance Co. Can now owns 51,795 shares of the scientific and technical instruments company’s stock valued at $4,395,000 after buying an additional 664 shares in the last quarter. Daiwa Securities Group Inc. bought a new stake in Cognex during the 2nd quarter valued at about $102,000. IFP Advisors Inc lifted its holdings in Cognex by 46.8% during the 2nd quarter. IFP Advisors Inc now owns 1,919 shares of the scientific and technical instruments company’s stock valued at $163,000 after buying an additional 612 shares in the last quarter. Finally, Retirement Systems of Alabama lifted its holdings in Cognex by 0.5% during the 2nd quarter. Retirement Systems of Alabama now owns 111,701 shares of the scientific and technical instruments company’s stock valued at $9,483,000 after buying an additional 607 shares in the last quarter. Hedge funds and other institutional investors own 84.25% of the company’s stock.

Cognex Co. (NASDAQ CGNX) opened at $64.38 on Friday. The company has a market cap of $10,735.01, a PE ratio of 45.75 and a beta of 1.50. Cognex Co. has a 12-month low of $31.18 and a 12-month high of $72.99.

Cognex (NASDAQ:CGNX) last posted its earnings results on Monday, October 30th. The scientific and technical instruments company reported $0.57 EPS for the quarter, beating analysts’ consensus estimates of $0.52 by $0.05. The business had revenue of $259.74 million for the quarter, compared to the consensus estimate of $255.95 million. Cognex had a net margin of 34.77% and a return on equity of 23.31%. The company’s revenue for the quarter was up 75.6% on a year-over-year basis. During the same quarter last year, the firm posted $0.31 EPS. analysts anticipate that Cognex Co. will post 1.39 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which was paid on Friday, December 1st. Shareholders of record on Friday, November 17th were given a dividend of $0.045 per share. This represents a $0.18 dividend on an annualized basis and a yield of 0.28%. The ex-dividend date was Thursday, November 16th. Cognex’s dividend payout ratio (DPR) is 13.28%.

CGNX has been the subject of a number of research analyst reports. Zacks Investment Research upgraded shares of Cognex from a “hold” rating to a “buy” rating and set a $69.00 price objective for the company in a report on Wednesday, November 1st. BidaskClub lowered shares of Cognex from a “buy” rating to a “hold” rating in a report on Thursday. Canaccord Genuity lifted their price objective on shares of Cognex from $47.50 to $60.00 and gave the company a “hold” rating in a report on Tuesday, October 31st. Robert W. Baird lifted their price objective on shares of Cognex from $50.00 to $62.00 and gave the company a “neutral” rating in a report on Tuesday, October 31st. Finally, Wolfe Research upgraded shares of Cognex from a “market perform” rating to an “outperform” rating in a report on Monday, August 14th. Two equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and five have issued a buy rating to the company’s stock. Cognex currently has an average rating of “Hold” and a consensus target price of $60.17.

In other Cognex news, Director Patrick Alias sold 5,000 shares of the firm’s stock in a transaction dated Monday, November 27th. The shares were sold at an average price of $143.54, for a total transaction of $717,700.00. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director Jeffrey Benjamin Miller sold 3,750 shares of the firm’s stock in a transaction dated Monday, November 6th. The shares were sold at an average price of $134.48, for a total transaction of $504,300.00. Following the transaction, the director now directly owns 3,750 shares in the company, valued at approximately $504,300. The disclosure for this sale can be found here. Insiders have sold a total of 148,750 shares of company stock worth $19,097,525 in the last three months. Insiders own 5.60% of the company’s stock.

WARNING: “Mackenzie Financial Corp Has $4.83 Million Stake in Cognex Co. (CGNX)” was reported by Sports Perspectives and is owned by of Sports Perspectives. If you are viewing this news story on another publication, it was stolen and republished in violation of United States and international trademark and copyright legislation. The correct version of this news story can be viewed at https://sportsperspectives.com/2017/12/09/mackenzie-financial-corp-has-4-83-million-stake-in-cognex-co-cgnx.html.

Cognex Company Profile

Cognex Corporation (Cognex) is a provider of machine vision products that capture and analyze visual information in order to automate tasks, primarily in manufacturing processes, where vision is required. The Company operates through the machine vision technology segment. The Company’s machine vision products are used to automate the manufacture and tracking of discrete items, such as mobile phones, aspirin bottles and automobile tires, by locating, identifying, inspecting and measuring them during the manufacturing or distribution process.

Institutional Ownership by Quarter for Cognex (NASDAQ:CGNX)

Receive News & Ratings for Cognex Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex Co. and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply